Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_provenance.
- NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_provenance.
- NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_assertion evidence source_evidence_literature NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_provenance.
- NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_assertion SIO_000772 20100636 NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_provenance.
- NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_assertion wasDerivedFrom befree-20150227 NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_provenance.
- NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_assertion wasGeneratedBy ECO_0000203 NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_provenance.